...
首页> 外文期刊>Applied and Environmental Microbiology >Inhibition of Listeria innocua in Cheddar Cheese by Addition of Nisin Z in Liposomes or by In Situ Production in Mixed Culture
【24h】

Inhibition of Listeria innocua in Cheddar Cheese by Addition of Nisin Z in Liposomes or by In Situ Production in Mixed Culture

机译:通过添加脂质体中的Nisin Z或通过混合培养原位生产来抑制切达干酪中的无毒李斯特菌

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The effect of addition of purified nisin Z in liposomes to cheese milk and of in situ production of nisin Z by Lactococcus lactis subsp. lactis biovar diacetylactis UL719 in the mixed starter on the inhibition of Listeria innocua in cheddar cheese was evaluated during 6 months of ripening. A cheese mixed starter culture containing Lactococcus lactis subsp. lactis biovar diacetylactis UL719 was selected for high-level nisin Z and acid production. Experimental cheddar cheeses were produced on a pilot scale, using the selected starter culture, from milk with added L. innocua (105 to 106 CFU/ml). Liposomes with purified nisin Z were prepared from proliposome H and added to cheese milk prior to renneting to give a final concentration of 300 IU/g of cheese. The nisin Z-producing strain and nisin Z-containing liposomes did not significantly affect cheese production and gross chemical composition of the cheeses. Immediately after cheese production, 3- and 1.5-log-unit reductions in viable counts of L. innocua were obtained in cheeses with encapsulated nisin and the nisinogenic starter, respectively. After 6 months, cheeses made with encapsulated nisin contained less than 10 CFU of L. innocua per g and 90% of the initial nisin activity, compared with 104 CFU/g and only 12% of initial activity in cheeses made with the nisinogenic starter. This study showed that encapsulation of nisin Z in liposomes can provide a powerful tool to improve nisin stability and inhibitory action in the cheese matrix while protecting the cheese starter from the detrimental action of nisin during cheese production.
机译:将脂质体中的纯化乳链菌肽Z添加到干酪乳中和乳酸乳球菌亚种原位生产乳链菌肽Z的作用。在成熟的6个月中,评估了混合发酵剂中的乳酸菌生物素二乙酰actis UL719对切达干酪中无毒李斯特菌的抑制作用。包含乳酸乳球菌亚种的奶酪混合发酵剂培养物。选择乳酸菌biovar diacetylactis UL719用于高水平乳链菌肽Z和产酸。使用添加的无毒李斯特菌(105至106 CFU / ml)的牛奶,使用选定的发酵剂培养物,以中试规模生产实验切达干酪。由原脂质体H制备具有纯化的乳链菌肽Z的脂质体,并在凝乳酶之前添加至干酪乳中,以使终浓度为300 IU / g干酪。产生乳链菌肽Z的菌株和含乳链菌肽Z的脂质体不会显着影响干酪的生产和干酪的总化学组成。奶酪生产后,立即用封装的乳链菌肽和乳链菌肽发酵剂分别获得了3个和1.5个对数单位的无毒李斯特菌活菌数减少。 6个月后,用包囊化的乳链菌肽制成的奶酪每克含少于10 CFU的无毒李斯特菌,占初始乳链菌肽活性的90%,相比之下,使用乳链菌肽制成的奶酪含104 CFU / g,仅占初始活性的12%起动机。这项研究表明,将乳链菌肽Z包裹在脂质体中可以提供一个强大的工具,以提高乳链菌肽的稳定性和在干酪基质中的抑制作用,同时保护干酪起始剂免受乳链菌素在干酪生产过程中的有害作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号